Navidea Biopharmaceuticals Inc. (NAVB): Share Price, Stock Analysis, Annual Report | Value Research Get Navidea Biopharmaceuticals Inc. (NAVB)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Biotechnology & Pharma Research

Navidea Biopharmaceuticals Inc. (NAVB)

NYSE: NAVB

  • Market Capitalisation info

    $16 Mln


  • 12 Month Earnings info

    $-12 Mln

  • Price to Earnings info

    --

$0.52

As on 12-Aug-2022 15:59 EDT

up-down-arrow $-0.02-4.31%

  • Prev Close info

    $0.54

  • Day's Openinfo

    $0.55

  • Today's Highinfo

    $0.55

  • Today's Lowinfo

    $0.52

  • Today's Volumeinfo

    52,206

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Navidea Biopharmaceuticals (NAVB)
-48.00 -20.00 -32.90 -69.41 1.32 -41.82 -38.96
S&P BSE Sensex
2.08 9.32 9.94 9.05 16.53 13.76 12.97
S&P Small-Cap 600
-8.13 14.13 12.23 -5.78 11.43 9.16 11.05
As on 12-Aug-2022
2021
2020
2019
2018
2017
2016
2015
Navidea Biopharmaceuticals (NAVB)
-53.49 70.63 -38.63 -71.17 -43.76 -52.07 -29.63
S&P Small-Cap 600
25.27 9.57 20.86 -9.70 11.73 24.74 -3.36
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        VP of Fin. & Admin.

        Ms. Erika L. Eves

        Sr. VP & Chief Medical Officer

        Dr. Michael Stanley Rosol Ph.D.

        Headquarters

        Dublin, OH
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $15.79 Mln

        • Revenue (TTM) info

          $0.41 Mln

        • Earnings (TTM) info

          $-11.75 Mln

        • Cash info

          $1.22 Mln

        • Total Debt info

          $0.32 Mln

        • Insider's Holding

          27.96%

        • Liquidity info

          Low

        • 52 Week range info

          $0.51 - 1.83

        • Shares outstanding info

          30,299,100

        • 10 Years Aggregate:

          CFO: $-68.57 Mln

          EBITDA: $-100.00 Mln

          Net Profit: $-124.02 Mln

        About The Company

        • Business

          Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics.

        • IPO Date

          10-Nov-1992

        • VP of Fin. & Admin.

          Ms. Erika L. Eves

        • Sr. VP & Chief Medical Officer

          Dr. Michael Stanley Rosol Ph.D.

        • Listing info

          NYSE: NAVB

        • Country

          United States

        • Headquarters info

          Dublin, OH

        • Website info

          https://www.navidea.com